Tie-ups of candy makers and nutritional product companies into a single firm called Bettera has culminated in a $1 billion acquisition by Catalent. The global contract manufacturing giant plans to leverage Bettera’s ability to produce gummies and chewables as a way to offer its customers new formulation options for nutraceutical products.
Nestlé first partnered with Pronutria last January, funding its nutraceutical approach to disease therapy, so its new stake in the company isn't surprising.
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.
The startup's building a portfolio of 1 billion protein sequences and tools to determine which disease they could help treat. Pronutria has raised $65 million to date for a nutraceutical approach to disease management - particularly those that cause muscle-wasting.